MetLife Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History

MetLife Investment Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$34.3M	Buy	77,148 +4,787	+7%	+$2.13M	0.2%	77
2025 Q1	$35.1M	Sell	72,361 -1,523	-2%	-$738K	0.19%	79
2024 Q4	$29.8M	Buy	73,884 +873	+1%	+$352K	0.16%	92
2024 Q3	$34M	Sell	73,011 -1,828	-2%	-$850K	0.19%	77
2024 Q2	$35.1M	Buy	74,839 +4,749	+7%	+$2.23M	0.21%	76
2024 Q1	$29.3M	Sell	70,090 -2,181	-3%	-$912K	0.2%	80
2023 Q4	$29.4M	Sell	72,271 -1,383	-2%	-$563K	0.21%	75
2023 Q3	$25.6M	Sell	73,654 -1,544	-2%	-$537K	0.2%	85
2023 Q2	$26.5M	Sell	75,198 -762	-1%	-$268K	0.19%	90
2023 Q1	$23.9M	Sell	75,960 -676	-0.9%	-$213K	0.17%	98
2022 Q4	$22.1M	Sell	76,636 -1,447	-2%	-$418K	0.17%	103
2022 Q3	$22.6M	Sell	78,083 -711	-0.9%	-$206K	0.19%	85
2022 Q2	$22.2M	Buy	78,794 +4,969	+7%	+$1.4M	0.17%	97
2022 Q1	$19.3M	Buy	73,825 +17,650	+31%	+$4.61M	0.12%	128
2021 Q4	$12.3M	Sell	56,175 -2,419	-4%	-$531K	0.1%	159
2021 Q3	$10.6M	Sell	58,594 -1,422	-2%	-$258K	0.1%	167
2021 Q2	$12.1M	Sell	60,016 -1,933	-3%	-$390K	0.11%	157
2021 Q1	$13.3M	Sell	61,949 -1,202	-2%	-$258K	0.12%	141
2020 Q4	$14.9M	Sell	63,151 -2,889	-4%	-$683K	0.14%	127
2020 Q3	$18M	Sell	66,040 -1,771	-3%	-$482K	0.2%	87
2020 Q2	$19.7M	Buy	67,811 +1,527	+2%	+$443K	0.22%	82
2020 Q1	$15.8M	Sell	66,284 -2,028	-3%	-$483K	0.21%	86
2019 Q4	$15M	Sell	68,312 -1,637	-2%	-$358K	0.16%	120
2019 Q3	$11.9M	Sell	69,949 -648	-0.9%	-$110K	0.13%	151
2019 Q2	$12.9M	Sell	70,597 -2,076	-3%	-$381K	0.14%	134
2019 Q1	$13.4M	Sell	72,673 -411	-0.6%	-$75.6K	0.15%	127
2018 Q4	$12.1M	Sell	73,084 -1,259	-2%	-$209K	0.15%	131
2018 Q3	$14.3M	Sell	74,343 -673	-0.9%	-$130K	0.15%	124
2018 Q2	$12.8M	Sell	75,016 -1,390	-2%	-$236K	0.15%	125
2018 Q1	$12.5M	Sell	76,406 -1,844	-2%	-$301K	0.15%	129
2017 Q4	$11.7M	Buy	+78,250	New	+$11.7M	0.13%	140